Last week, Japanese health authorities granted priority review status for Nexavar to treat liver cancer.
TOKYO (Reuters) - German drug maker Bayer AG said on Monday that its drug Nexavar had been approved in Japan for the treatment of kidney cancer.
Last week, Japanese health authorities granted priority review status for Nexavar to treat liver cancer.
(Reporting by Edwina Gibbs)
